EDGAR Filing Documents for 0000950170-23-004145

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000950170-23-004145

Filing Date

2023-02-23

Accepted

2023-02-23 16:32:22

Documents

116

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	bbio-20221231.htm iXBRL	10-K	7405683
2	EX-10.16	bbio-ex10_16.htm	EX-10	74742
3	EX-10.17	bbio-ex10_17.htm	EX-10	16446
4	EX-10.18	bbio-ex10_18.htm	EX-10	16533
5	EX-10.33	bbio-ex10_33.htm	EX-10	1082226
6	EX-21	bbio-ex21.htm	EX-21	79106
7	EX-23.1	bbio-ex23_1.htm	EX-23	8658
8	EX-31.1	bbio-ex31_1.htm	EX-31	15781
9	EX-31.2	bbio-ex31_2.htm	EX-31	13616
10	EX-32.1	bbio-ex32_1.htm	EX-32	10000
11	EX-32.2	bbio-ex32_2.htm	EX-32	10055
12	GRAPHIC	img187071172_0.jpg	GRAPHIC	60670
13	GRAPHIC	img187071172_1.jpg	GRAPHIC	104046
14	GRAPHIC	img187071172_2.jpg	GRAPHIC	41707
15	GRAPHIC	img187071172_3.jpg	GRAPHIC	20150
16	GRAPHIC	img187071172_4.jpg	GRAPHIC	77666
17	GRAPHIC	img187071172_5.jpg	GRAPHIC	68892
18	GRAPHIC	img187071172_6.jpg	GRAPHIC	190341
	Complete submission text file	0000950170-23-004145.txt		27733068

Data Files

Seq	Description	Document	Type	Size
19	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	bbio-20221231_def.xml	EX-101.DEF	554543
20	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	bbio-20221231.xsd	EX-101.SCH	140143
21	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	bbio-20221231_lab.xml	EX-101.LAB	1033003
22	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	bbio-20221231_pre.xml	EX-101.PRE	791752
23	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	bbio-20221231_cal.xml	EX-101.CAL	111041
110	EXTRACTED XBRL INSTANCE DOCUMENT	bbio-20221231_htm.xml	XML	5318680

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304

Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740

BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)